(Q33870409)

29 July 2017

title

Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease (English)

1 reference

Paulo Marcos Matta Guedes

29 July 2017

0 references

1 reference

ORCID Public Data File 2021

author name string

Paulo M M Guedes

1

1 reference

29 July 2017

Fabiana S Oliveira

2

1 reference

29 July 2017

Fredy R S Gutierrez

3

1 reference

29 July 2017

Grace Kelly da Silva

4

1 reference

29 July 2017

Gerson Jhonatan Rodrigues

5

1 reference

29 July 2017

Lusiane Maria Bendhack

6

1 reference

29 July 2017

Douglas W Franco

7

1 reference

29 July 2017

Maria A Do Valle Matta

8

1 reference

29 July 2017

Dario S Zamboni

9

1 reference

29 July 2017

Roberto Santana da Silva

10

1 reference

29 July 2017

João Santana Silva

11

1 reference

29 July 2017

language of work or name

English

0 references

publication date

27 January 2010

1 reference

British Journal of Pharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

160

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

270-282

1 reference

In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Nitric oxide and the immune response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

The role of nitric oxide in innate immunity.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina

5 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

5 July 2018

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Parasitological cure of Chagas disease: is it possible? Is it relevant?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Sensitivity of parasites to free radical damage by antiparasitic drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Chagas disease in bone marrow transplantation: an approach to preemptive therapy

5 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Epidemiology of Chagas disease in non-endemic countries: the role of international migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00576.X

Observations on immunity to superinfections in mice experimentally inoculated with Trypanosoma cruzi and subjected to treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Long term evaluation of etiological treatment of chagas disease with benznidazole.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

[Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases]

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

[Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Central motor conduction in human chronic Chagas' disease

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy

10 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874850

Nitrate synthesis in the germfree and conventional rat

10 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20128813

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1476-5381.2009.00576.X

1 reference

29 July 2017

1 reference

29 July 2017

1 reference